Patent · US Active

Transgenic mouse models of Aβ overexpression

US8283517B2 · kind B2 · utility

3Cited by
14References
29Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 12, 2008
Grant dateOct 9, 2012
Priority date
Expiry dateDec 12, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2830/008
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

A transgenic non-human animal, in particular a transgenic mouse encoding Aβ peptide proteins, which have been implicated in Aβ peptide-related diseases. Cells and cell lines comprising transgenes encoding for Aβ peptide. Methods and compositions for evaluating agents that affect Aβ peptide, for use in compositions for the treatment of Aβ peptide-related diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.